A 35-year-old woman from Delhi presents with a 2-month history of painless left ear discharge and conductive hearing loss. Otoscopy shows a whitish, granular mass in the external auditory canal with surrounding erythema and edema. Audiometry confirms air-bone gap of 35 dB. CT temporal bone is normal with no bone erosion. What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis: Congenital Cholesteatoma This patient presents with **congenital cholesteatoma** (not acquired). Key diagnostic clues: - **Whitish, granular mass in the external auditory canal** (not in the middle ear) - **No bone erosion on CT** (early-stage disease) - **Conductive hearing loss** (ossicular involvement without ossicular erosion—indicates stapes fixation or ossicular displacement) - **No history of perforation or chronic discharge** (distinguishes from acquired cholesteatoma) **High-Yield:** Congenital cholesteatoma arises from **epithelial remnants** in the external auditory canal (Toynbee's theory) and is distinct from acquired cholesteatoma, which results from retraction pockets or perforation. ## Management of Congenital Cholesteatoma ```mermaid flowchart TD A[Congenital cholesteatoma<br/>confirmed]:::outcome --> B{Bone erosion<br/>present?}:::decision B -->|Yes| C[Urgent surgery<br/>CWD mastoidectomy]:::urgent B -->|No| D[Elective surgery<br/>within 4-6 weeks]:::action D --> E{Ossicular involvement?}:::decision E -->|Yes| F[Endaural approach<br/>+ ossicular assessment]:::action E -->|No| G[Simple canal wall up<br/>excision]:::action F --> H[Ossiculoplasty if needed<br/>same stage]:::action ``` **Key Point:** Even **without bone erosion**, congenital cholesteatoma is a **surgical disease** because: 1. It will progressively erode bone if left untreated 2. It causes conductive hearing loss via ossicular displacement/fixation 3. Risk of infection and intracranial extension increases with time 4. Early excision prevents complications and allows ossicular reconstruction ## Why Endaural Approach Is Chosen | Approach | Indication | Advantage | | --- | --- | --- | | **Endaural** | Small, canal-based lesion without mastoid involvement | Preserves canal anatomy, direct visualization, ossicular assessment | | **Postauricular (CWD)** | Large lesion with mastoid extension or bone erosion | Complete disease eradication, but sacrifices canal | | **Transcanal endoscopic** | Recurrent/residual disease, revision cases | Minimally invasive, good visualization | **Clinical Pearl:** The **air-bone gap of 35 dB** suggests ossicular involvement (stapes fixation or displacement by the mass). Intraoperative ossicular chain assessment is essential to determine whether ossiculoplasty is needed at the time of excision. ## Why Other Options Are Incorrect - **Oral fluoroquinolone + topical steroids:** Cholesteatoma is not an infection—it is an epithelial tumor. Antibiotics and steroids do not halt epithelial proliferation or prevent progressive bone erosion. This is a dangerous delay that risks complications. - **Watchful waiting with 3-monthly review:** Congenital cholesteatoma is **progressive**. Observation allows bone erosion to develop, increasing surgical morbidity and risk of intracranial complications. Early elective surgery is the standard of care. - **MRI brain to exclude intracranial extension:** MRI is not indicated as a first step when CT shows no bone erosion. Intracranial complications are rare in early-stage disease without osseous erosion. MRI may be considered **post-operatively** if there is suspicion of residual disease or complications, but it should not delay surgery. **Mnemonic:** **CANAL = Congenital Anomaly Needs Ablation and Listing** — congenital cholesteatoma requires elective surgical excision even without bone erosion.